Reducing the Sublimation Tendency of Ligustrazine through Salt Formation-Reference-Cited by-同舟云学术

Reducing the Sublimation Tendency of Ligustrazine through Salt Formation

Published:2020-01-22 Issue:3 Volume:20 Page:2057-2063
ISSN:1528-7483
Container-title:Crystal Growth & Design
language:en
Short-container-title:Crystal Growth & Design

Author:

Hu Shenye¹^ORCID,Wang Chenguang¹^ORCID,He Xin²,Sun Changquan Calvin¹^ORCID

Affiliation:

1. Pharmaceutical Materials Science and Engineering Laboratory, Department of Pharmaceutics, College of Pharmacy, University of Minnesota, Minneapolis, Minnesota 55455, United States

2. College of Veterinary Medicine, Hebei Agricultural University, Baoding, Hebei 071000, China

Publisher

American Chemical Society (ACS)

Subject

Condensed Matter Physics,General Materials Science,General Chemistry

Link

https://pubs.acs.org/doi/pdf/10.1021/acs.cgd.9b01704

Reference35 articles.

1. Polymorphs, Salts, and Cocrystals: What’s in a Name?

2. Crystal engineering: structure, property and beyond

3. Crystal engineering of the composition of pharmaceutical phases. Do pharmaceutical co-crystals represent a new path to improved medicines?

4. Generally recognized as safe (GRAS): history and description

5. Cocrystals of Quercetin with Improved Solubility and Oral Bioavailability

Cited by 16 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Tetramethylpyrazine Cocrystals with Cinnamic Acid and Its Derivatives: Crystal Structures, Theoretical Computations, and Sublimation Behavior Studies;Crystal Growth & Design;2024-08-16

2. Polymorphs of praziquantel–succinic acid cocrystal: Crystal structure, thermodynamic relationship, and improved pharmaceutical performance;Journal of Molecular Structure;2024-07

3. New Cocrystals of Ligustrazine: Enhancing Hygroscopicity and Stability;Molecules;2024-05-08

4. Cocrystallization improves the tabletability of ligustrazine despite a reduction in plasticity;International Journal of Pharmaceutics;2024-04

5. Enhancing the Bioavailability of a Novel Enrofloxacin Salt by Inhibiting Precipitation via a Crystallization Inhibitor;Crystal Growth & Design;2024-03-21